Results 181 to 190 of about 20,467 (239)

Cost-effectiveness of anti-vascular endothelial growth factor and macular laser treatments for people with centre-involving diabetic macular oedema and central retinal thickness of at least 400 micrometres. [PDF]

Eye (Lond)
Luckham K, Tebbs H, Dadswell C, Yosef A, Claxton L, Kelley K, Taske N, Burgess PI, Dinah C, Lois N, Mohiuddin S.   +10 more
europepmc   +1 more source

Predicting the need for diabetic macular oedema treatment from photographic screening in the Singapore Integrated Diabetic Retinopathy Programme (SiDRP). [PDF]

Eye (Lond)
Poh SSJ, Teo KYC, Goh RA, Lee QX, Hamzah H, Sim SSC, Tan CS, Tan NC, Wong TY, Tan GSW.   +9 more
europepmc   +1 more source

Diabetic Macular Oedema and Retinal Imaging

European Ophthalmic Review, 2017
openaire   +1 more source

Burden of Disease Study of Patients with Diabetic Macular Oedema in Spain. [PDF]

Ophthalmol Ther
Ruiz-Moreno JM, Gámez Lechuga M, Calvo P, Merino M, Martín Lorenzo T, Maravilla-Herrera P, Gil Jiménez B, Abraldes MJ.   +7 more
europepmc   +1 more source

What have we learned from a decade treating patients with diabetic macular oedema with 0.19 mg fluocinolone acetonide intravitreal implant? [PDF]

Eye (Lond)
Kodjikian L, Duarte L, Singh P, Habib M, Gonzalez V.   +4 more
europepmc   +1 more source

Use of a multifocal electroretinogram to evaluate the therapeutic effect of a single intravitreal dexamethasone implant, Ozurdex^®, for refractory diabetic macular oedema. [PDF]

Int J Retina Vitreous
Mohammed ARA, Othman MFS, Khairat YM, Abdelrahman AAM.   +3 more
europepmc   +1 more source

Summary of Research: Cost‑Effectiveness of Faricimab in the Treatment of Diabetic Macular Oedema (DMO): A UK Analysis. [PDF]

Ophthalmol Ther
Bührer C, Paling T, Gale R, Paulo T, Bagijn M.   +4 more
europepmc   +1 more source

How intravitreal anti-vascular endothelial growth factor initial dosing impacts patient outcomes in diabetic macular oedema. [PDF]

BMC Ophthalmol
Singh RP, Tabano D, Kuo BL, LaPrise A, Leng T, Kim E, Hatfield M, Garmo V.   +7 more
europepmc   +1 more source

Non-ophthalmic parameters and the presence of clinically significant macular oedema [PDF]

, 2006
Gorst-Rasmussen, Anders, Knudsen, L.L., Lervang, H.H., Lundbye-Christensen, Søren   +3 more
core   +1 more source

Elevated aqueous TNF-α levels are associated with more severe functional and anatomic findings in eyes with diabetic macular oedema. [PDF]

Clin Exp Ophthalmol
Chew S, Tran T, Sanfilippo P, Lim LL, Sandhu SS, Wickremasinghe S.   +5 more
europepmc   +1 more source